RA Capital Management »

Assembly Biosciences shares owned by RA Capital Management

Quarter-by-quarter ownership of Assembly Biosciences (ASMB) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Assembly Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Assembly Biosciences held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Assembly Biosciences by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $26M 1.0M 25.60

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Rhythm Pharmaceuticals SH (RYTM)
Vaxcyte SH (PCVX)
Avidity Biosciences SH (RNA)
Cidara Therapeutics SH (CDTX)
Sionna Therapeutics SH (SION)
89bio SH (ETNB)
Newamsterdam Pharma Co Nv SH (NAMS)
Mineralys Therapeutics SH (MLYS)
Janux Therapeutics SH (JANX)
Arcellx SH (ACLX)
Lenz Therapeutics SH (LENZ)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
Wave Life Sciences SH (WVE)

View all positions for RA Capital Management

Top funds holding Assembly Biosciences

Gilead Sciences
Farallon Capital Management
RA Capital Management
Commodore Capital
Henderson Group
Vanguard Group
Frazier Life Sciences Management
Blackstone Group
Caption Management
Point72 Asset Management
Parkman Healthcare Partners
Franklin Resources
Susquehanna International
BlackRock
Renaissance Technologies

View all funds holding Assembly Biosciences